Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
24,52 USD | -2,15% | +7,54% | -24,51% |
02/05 | CORCEPT THERAPEUTICS INCORPORATED : Een koopadvies van Truist Securities | ZM |
01/05 | Transcript : Corcept Therapeutics Incorporated, Q1 2024 Earnings Call, May 01, 2024 |
Vakgebied
Aantal werknemers: 352
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 402 | 100,0 % | 482 | 100,0 % | +20,04% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 402 | 100,0 % | 482 | 100,0 % | +20,04% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 13-05-98 |
Atabak Mokari
DFI | Director of Finance/CFO | 47 | 01-03-21 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-06-12 |
Hazel Hunt
CTO | Chief Tech/Sci/R&D Officer | 64 | 01-01-11 |
Jerry Pan
IRC | Investor Relations Contact | - | 01-10-21 |
Amy E. Flood
IRO | Public Communications Contact | - | 12-07-21 |
William Guyer
PRN | Corporate Officer/Principal | 56 | 16-08-21 |
Monica Tellado
PRN | Corporate Officer/Principal | 51 | 01/11 |
Sean Maduck
PRN | Corporate Officer/Principal | 47 | 01-01-12 |
Gary Robb
SEC | Corporate Secretary | 61 | 01-09-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 13-05-98 |
Gregg Alton
BRD | Director/Board Member | 58 | 12-03-20 |
George Baker
BRD | Director/Board Member | 81 | 01-01-99 |
James Wilson
CHM | Chairman | 80 | 01-01-99 |
David Mahoney
BRD | Director/Board Member | 69 | 01-07-04 |
Daniel Swisher
BRD | Director/Board Member | 61 | 18-06-15 |
Kimberly Park
BRD | Director/Board Member | 60 | 18-09-19 |
Gillian Cannon
BRD | Director/Board Member | 60 | 23-11-20 |
Joshua Murray
BRD | Director/Board Member | 40 | 09-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 135 312 088 | 92 262 472 ( 68,18 %) | 31 200 000 ( 23,06 %) | 68,18 % |
Bedrijfsgegevens
Corcept Therapeutics, Inc.
149 Commonwealth Drive
94025, Menlo Park
+650 327 3270
http://www.corcept.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-24,51% | 2,55 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. | |
-3,40% | 157 mld. |
- Beurs
- Aandelen
- Koers CORT
- Onderneming Corcept Therapeutics Incorporated